Clopidogrel Increases Blood Transfusion and Hemorrhagic Complications in Patients Undergoing Cardiac Surgery

Annals of Thoracic Surgery

Volumn 89, Issue 2, 2010, Pages 397-402

  Herman, Christine R ^a   Buth, Karen J ^a   Kent, Blaine A ^a   Hirsch, Gregory M ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; TICLOPIDINE;

EID: 74549196918     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.10.051     Document Type: Article

References (21)

1. Lewis B.S., Mehta S.R., Fox K.A.A., et al., CURE Trial Investigators. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Am Heart J 150 (2005) 1177-1184
2. Sabatine M.S., Cannon C.P., Gibson C.M., et al., CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
3. Chen Z.M., Jiang L.X., Chen Y.P., et al., COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
4. Mak K.H., Belli G., Ellis S.G., and Moliterno D.J. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 27 (1996) 494-503
5. Mishkel G.J., Aguirre F.V., Ligon R.W., Rocha-Singh K.J., and Lucore C.L. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 34 (1999) 1884-1890
6. Kolansky D.M., Klugherz B.D., Curran S.C., et al. Combination therapy with clopidogrel and aspirin after coronary stenting. Catheter Cardiovasc Interv 50 (2000) 276-279
7. Antman E.M., Hand M., Armstrong P.W., et al., 2004 Writing Committee Members. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, developed in collaboration with the Canadian Cardiovascular Society, endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 117 (2008) 296-329
8. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction). Circulation 116 (2007) 803-877
9. King S.B., Smith S.C., Hirshfeld J.W., et al., 2005 Writing Committee Members. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing committee. Circulation 117 (2008) 261-295
10. Kang W., Theman T.E., Reed J.F., Stoltzfus J., and Weger N. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery. J Surg Educ 64 (2007) 88-92
11. Englberger L., Faeh B., Berdat P.A., Eberli F., Meier B., and Carrel T. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 26 (2004) 96-101
12. Karabulut H., Toraman F., Evrenkaya S., Goksel O., Tarcan S., and Alhan C. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery. Eur J Cardiothorac Surg 25 (2004) 419-423
13. Mehta R.H., Roe M.T., Mulgund J., et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48 (2006) 281-286
14. Ley S.J. Quality care outcomes in cardiac surgery: the role of evidence-based practice. AACN Clin Issues 12 (2001) 606-617
15. Kapetanakis E.I., Medlam D.A., Petro K.R., et al. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?. Circulation 113 (2006) 1667-1674
16. Murphy G.J., Reeves B.C., Rogers C.A., Rizvi S.I.A., Culliford L., and Angelini G.D. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116 (2007) 2544-2552
17. Moulton M.J., Creswell L.L., Mackey M.E., Cox J.L., and Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 111 (1996) 1037-1046
18. Ascione R., Ghosh A., Rogers C.A., Cohen A., Monk C., and Angelini G.D. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. Ann Thorac Surg 79 (2005) 1210-1216
19. Choudhry N.K., Levin R., and Avorn J. The economic consequences of non-evidence-based clopidogrel use. Am Heart J 155 (2008) 904-909
20. Fergusson D.A., Hebert P.C., Mazer C.D., et al., BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
21. Karkouti K., Beattie W.S., Arellano R., et al. Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 118 (2008) 331-338